Aetna Inc. (NYSE:AET) had its price target lifted by Jefferies Group LLC from $163.00 to $165.00 in a report published on Friday morning. They currently have a hold rating on the stock.

A number of other analysts have also recently issued reports on the company. Argus reaffirmed a buy rating and issued a $185.00 price objective (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Citigroup Inc. initiated coverage on Aetna in a research report on Wednesday, June 28th. They issued a buy rating and a $180.00 price objective for the company. BidaskClub cut Aetna from a strong-buy rating to a buy rating in a research report on Wednesday, July 19th. Morgan Stanley raised their price objective on Aetna from $172.00 to $179.00 and gave the company an overweight rating in a research report on Thursday, August 17th. Finally, Zacks Investment Research raised Aetna from a hold rating to a buy rating and set a $170.00 price objective for the company in a research report on Tuesday, July 4th. Seven investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Aetna currently has a consensus rating of Buy and a consensus price target of $161.10.

Shares of Aetna (NYSE:AET) traded down 0.93% on Friday, reaching $153.06. The company’s stock had a trading volume of 2,000,368 shares. The firm has a market cap of $50.83 billion, a price-to-earnings ratio of 33.98 and a beta of 0.53. Aetna has a 1-year low of $104.59 and a 1-year high of $164.52. The company’s 50 day moving average is $158.23 and its 200-day moving average is $148.87.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same period last year, the firm posted $2.21 earnings per share. The business’s revenue was down 2.7% on a year-over-year basis. Equities research analysts expect that Aetna will post $9.55 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Aetna Inc. (AET) Given New $165.00 Price Target at Jefferies Group LLC” was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.dailypolitical.com/2017/10/14/aetna-inc-aet-given-new-165-00-price-target-at-jefferies-group-llc.html.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.31%. Aetna’s dividend payout ratio (DPR) is presently 43.67%.

In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of AET. BlackRock Inc. increased its stake in shares of Aetna by 3,374.9% in the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after purchasing an additional 29,828,390 shares during the last quarter. FMR LLC increased its stake in shares of Aetna by 73.8% in the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after purchasing an additional 5,833,567 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after purchasing an additional 4,283,553 shares during the last quarter. Capital World Investors increased its stake in shares of Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after purchasing an additional 1,688,767 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Aetna by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after purchasing an additional 838,578 shares during the last quarter. Institutional investors own 89.52% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.